Explorer les evidences

36 %The percentage of the diabetic population who had ever received a blood glucose measurement had a median of 36%.

Cameroundiabète (non précisé)observé 2005-15publié 2016The lancet. Diabetes & endocrinologyeurope_pmcdocument de 10 observations

78 casesThe total number of suspected cases of epilepsy (SCE) recorded by the CDDs across all villages was 78.

CamerounépilepsieHAL · Unilimdocument de 53 observations

9 %Phylogenetic analysis of the gp41 region of 123 HIV-1-seropositive specimens from Cameroon showed that 11 (9%) were subtype G.

CamerounVIH/sidapublié 2000AIDS Research and Human RetrovirusesOpenAlexdocument de 7 observations

Glycemic control of adolescents with type 1 diabetes remains very poor in Cameroon.

Cameroundiabète de type 1publié 2019BMC research noteseurope_pmcdocument de 4 observationsDOI 10.1186/s13104-019-4054-1

89 casesThe total number of suspected cases of epilepsy (SCE) recorded by the research team across all villages was 89.

CamerounépilepsieHAL · Unilimdocument de 53 observations

1,32 %The prevalence of epilepsy recorded by the CDDs across all villages was 1.32%.

CamerounépilepsieHAL · Unilimdocument de 53 observations

75 %Le PSNLP 2011-2015 visait à réduire de 75 % la mortalité et la morbidité dues au paludisme par rapport à la situation de 2000 d’ici 2015.

Camerounpaludismeobservé 2015HAL · Unilimdocument de 98 observations

13,8 %HCV seroprevalence in Cameroon is 13.8%.

Camerounhépatite Cpublié 2007Emerging infectious diseasesOpenAlexdocument de 7 observationsDOI 10.3201/eid1303.061069

3 yearsThe median duration of diagnosed diabetes was 3 years (interquartile range: 0.5–5.0 years) among patients with type 2 diabetes in Cameroon.

Cameroundiabète de type 2publié 2012Diabetology & metabolic syndromeeurope_pmcdocument de 4 observationsDOI 10.1186/1758-5996-4-22

The prevalence of non-subtype-B HIV-1 strains continues to increase in industrialized countries.

CamerounVIH/sidapublié 2000Journal of Clinical MicrobiologyOpenAlexdocument de 19 observations

9,5 %At diagnosis, 9.5% of type 1 diabetic patients have retinopathy.

Cameroundiabète de type 1 · retinopathypublié 2003Journal of cardiovascular riskeurope_pmcdocument de 10 observations

19 sitesSIVgor antibody-positive samples were not found at 19 other sites, including 3 in the range of the Eastern gorillas.

CamerounSIVgorpublié 2009Journal of VirologyOpenAlexdocument de 4 observationsDOI 10.1128/jvi.02129-09

Co-treatment with Octreotide and Pegvisomant normalized biological disease activity reflected by hormone levels in a 36 year-old male patient with a somatotropin and thyreotropin secreting pituitary adenoma.

Camerounsomatotropin and thyreotropin secreting pituitary adenomapublié 2006Annales d'endocrinologieeurope_pmcdocument de 3 observations

63 huntersScreening of peripheral blood mononuclear cell DNA from 63 HTLV-seroreactive, PCR-negative hunters did not identify human infections with a highly divergent STLV-3 subtype.

CamerounSTLV-3publié 2009Emerging infectious diseasesOpenAlexdocument de 3 observationsDOI 10.3201/eid1502.080584

28 %Hypertension prevalence in the Guinea-Savannah agroecological zone of Cameroon was 28% [95% CI 20.1–35.9].

Camerounhypertension artériellepublié 2019Journal of hypertensioneurope_pmcdocument de 20 observationsDOI 10.1097/hjh.0000000000002165

55,4 %Over half of the African adult patients with type 1 diabetes mellitus (55.4%) stated that the cost of test strips limited regular glycemic monitoring.

Cameroundiabète de type 1publié 2020Medicineeurope_pmcdocument de 9 observations

5 %Three nef sequences (5%) were neither obviously recombinant nor easily classifiable into any of the known HIV-1M clades.

CamerounVIH/sidapublié 2013Virology JournalOpenAlexdocument de 7 observationsDOI 10.1186/1743-422x-10-29

24 500 000 casesIn 2017, there were 24.5 million incident cancer cases worldwide.

Camerouncancer (non précisé)observé 2017publié 2019JAMA oncologyeurope_pmcdocument de 25 observationsDOI 10.1001/jamaoncol.2019.2996

22 patientsAmong 109 Cameroonian patients with sickle cell disease (SCD), 22 patients harbored two variant alleles at either the homozygous or compound heterozygous state and were considered to be expressing a variant (i.e. weak and/or partial) D phenotype.

Cameroundrépanocytoseobservé 2023HAL · Unilimdocument de 45 observations

200 per_100000In 2010, age-standardised death rates from cardiovascular diseases, chronic kidney disease, and diabetes attributable to the combined effects of high blood pressure, high BMI, high glucose, and high cholesterol were less than 200 deaths per 100 000 for men in Japan.

Cameroundiabète (non précisé) · maladie rénale chronique · maladies cardiovasculairesobservé 2010publié 2014The lancet. Diabetes & endocrinologyeurope_pmcdocument de 28 observationsDOI 10.1016/s2213-8587(14)70102-0

Le paludisme constitue la première cause de morbidité au Cameroun.

CamerounpaludismeHAL · Unilimdocument de 98 observations

928 000 IU/mLIn coinfected patients, the median HCV viral load was 928,000 IU/mL.

Camerounhépatite Cpublié 2010BMC Public HealthOpenAlexdocument de 6 observationsDOI 10.1186/1471-2458-10-105

86,6 %The age-standardized awareness rate for coincident hypertension and diabetes was 86.6% among men in a semi-urban population in Bafoussam, Cameroon.

Cameroundiabète (non précisé) · hypertension artérielleobservé 2012publié 2014BMC public healtheurope_pmcdocument de 24 observationsDOI 10.1186/1471-2458-14-696

8,3 %The RHCE*03 (*cE) allelic background was found in 18 out of 216 total alleles (8.3%) among Cameroonian patients with sickle cell disease (SCD).

CameroundrépanocytoseHAL · Unilimdocument de 45 observations

276 samples276 out of 424 HIV-positive samples were identified as HIV-1 subtype A.

CamerounHIV-1 subtype Apublié 1998PubMedOpenAlexdocument de 10 observations